Who owns Carmell Therapeutics Corp - US?
- Ticker: CTCX
- CUSIP Number: 142922103
Tip: Access positions for across all investors
Analyze quarterly positions in Carmell Therapeutics Corp - US with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Carmell Therapeutics Corp - US stock
Who bought or sold Carmell Therapeutics Corp - US this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
---|---|---|---|---|---|
Hubbell Strickland Wealth Management | 206k | $83k | 100% | Sep 2024 |
|
Vanguard Group | 182k | $242k | 5% | Jun 2024 |
|
Carnegie Mellon University | 103k | $137k | 0% | Jun 2024 |
|
Geode Capital Management | 98k | $39k | 18% | Sep 2024 |
|
BlackRock | 63k | $25k | 100% | Sep 2024 |
|
Northern Trust | 53k | $21k | -2% | Sep 2024 |
|
Warberg Asset Management | 45k | $18k | 0% | Sep 2024 |
|
OZ Management | 38k | $15k | 100% | Sep 2024 |
|
BlackRock | 36k | $48k | 15% | Jun 2024 |
|
Bangor Savings Bank | 35k | $14k | 100% | Sep 2024 |
|
Commonwealth Equity Services | 34k | $14k | 100% | Sep 2024 |
|
St. Denis J. Villere & Co | 18k | $7.1k | 100% | Sep 2024 |
|
Virtu Financial | 11k | $4.0k | 100% | Sep 2024 |
|
Tower Research Capital | 2.2k | $2.9k | 65% | Jun 2024 |
|
Morgan Stanley | 2.1k | $2.8k | 0% | Jun 2024 |
|
Bank of America Corporation | 623.00 | $249.200000 | 442% | Sep 2024 |
|
Wolverine Asset Management | 163.00 | $65.004400 | 100% | Sep 2024 |
|
Royal Bank of Canada | 100.00 | $0 | 100% | Sep 2024 |
|
Jpmorgan Chase & Co | 33.00 | $12.998700 | -27% | Sep 2024 |
|
Who sold out of Carmell Therapeutics Corp - US?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
---|---|---|---|
Capital Advisors | Jun 2024 | 89.00 | $0 |